488 related articles for article (PubMed ID: 33933030)
1. Effects of an interprofessional Quality Circle-Deprescribing Module (QC-DeMo) in Swiss nursing homes: a randomised controlled trial.
Cateau D; Ballabeni P; Niquille A
BMC Geriatr; 2021 May; 21(1):289. PubMed ID: 33933030
[TBL] [Abstract][Full Text] [Related]
2. Implementation of interprofessional quality circles on deprescribing in Swiss nursing homes: an observational study.
Mena S; Moullin JC; Schneider M; Niquille A
BMC Geriatr; 2023 Oct; 23(1):620. PubMed ID: 37789286
[TBL] [Abstract][Full Text] [Related]
3. Effects of an interprofessional deprescribing intervention in Swiss nursing homes: the Individual Deprescribing Intervention (IDeI) randomised controlled trial.
Cateau D; Ballabeni P; Niquille A
BMC Geriatr; 2021 Nov; 21(1):655. PubMed ID: 34798826
[TBL] [Abstract][Full Text] [Related]
4. Deprescribing in nursing homes: Protocol for nested, randomised controlled hybrid trials of deprescribing interventions.
Cateau D; Ballabeni P; Mena S; Bugnon O; Niquille A
Res Social Adm Pharm; 2021 Apr; 17(4):786-794. PubMed ID: 32622774
[TBL] [Abstract][Full Text] [Related]
5. Evolution of potentially inappropriate medication use in nursing homes: Retrospective analysis of drug consumption data.
Cateau D; Bugnon O; Niquille A
Res Social Adm Pharm; 2021 Apr; 17(4):701-706. PubMed ID: 32798051
[TBL] [Abstract][Full Text] [Related]
6. Impact of a pharmacist-administered deprescribing intervention on nursing home residents: a randomized controlled trial.
Balsom C; Pittman N; King R; Kelly D
Int J Clin Pharm; 2020 Aug; 42(4):1153-1167. PubMed ID: 32494991
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of elderly patients with polypharmacy who refuse to participate in an in-hospital deprescribing intervention: a retrospective cross-sectional study.
Komagamine J; Sugawara K; Hagane K
BMC Geriatr; 2018 Apr; 18(1):96. PubMed ID: 29665778
[TBL] [Abstract][Full Text] [Related]
8. Spread and scale of an electronic deprescribing software to improve health outcomes of older adults living in nursing homes: study protocol for a stepped wedge cluster randomized trial.
Nadeau ME; Henry JL; Lee TC; Bortolussi-Courval É; Goodine C; McDonald EG
Trials; 2021 Nov; 22(1):763. PubMed ID: 34727956
[TBL] [Abstract][Full Text] [Related]
9. Multidisciplinary intervention to improve medication safety in nursing home residents: protocol of a cluster randomised controlled trial (HIOPP-3-iTBX study).
Krause O; Wiese B; Doyle IM; Kirsch C; Thürmann P; Wilm S; Sparenberg L; Stolz R; Freytag A; Bleidorn J; Junius-Walker U;
BMC Geriatr; 2019 Jan; 19(1):24. PubMed ID: 30683060
[TBL] [Abstract][Full Text] [Related]
10. The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial.
Bayliss EA; Shetterly SM; Drace ML; Norton J; Green AR; Reeve E; Weffald LA; Wright L; Maciejewski ML; Sheehan OC; Wolff JL; Gleason KS; Kraus C; Maiyani M; Du Vall M; Boyd CM
Trials; 2020 Jun; 21(1):542. PubMed ID: 32552857
[TBL] [Abstract][Full Text] [Related]
11. Use and Deprescribing of Potentially Inappropriate Medications in Frail Nursing Home Residents.
Fournier A; Anrys P; Beuscart JB; Dalleur O; Henrard S; Foulon V; Spinewine A
Drugs Aging; 2020 Dec; 37(12):917-924. PubMed ID: 33047252
[TBL] [Abstract][Full Text] [Related]
12. Balancing medication use in nursing home residents with life-limiting disease.
Paque K; Elseviers M; Vander Stichele R; Pardon K; Vinkeroye C; Deliens L; Christiaens T; Dilles T
Eur J Clin Pharmacol; 2019 Jul; 75(7):969-977. PubMed ID: 30834473
[TBL] [Abstract][Full Text] [Related]
13. Nursing home team-care deprescribing study: a stepped-wedge randomised controlled trial protocol.
Kua CH; Yeo CYY; Char CWT; Tan CWY; Tan PC; Mak VS; Lee SWH; Leong IY
BMJ Open; 2017 May; 7(5):e015293. PubMed ID: 28490560
[TBL] [Abstract][Full Text] [Related]
14. Implementation of a compulsory clinical pharmacist-led medication deprescribing intervention in high-risk seniors in the emergency department.
Jovevski JJ; Smith CR; Roberts JL; Dev S; Iloabuchi TC; Gruber EA; Williams MJ; Slaven JE; Mitchell AM
Acad Emerg Med; 2023 Apr; 30(4):410-419. PubMed ID: 36794336
[TBL] [Abstract][Full Text] [Related]
15. Benzodiazepine Use and Deprescribing in Belgian Nursing Homes: Results from the COME-ON Study.
Evrard P; Henrard S; Foulon V; Spinewine A
J Am Geriatr Soc; 2020 Dec; 68(12):2768-2777. PubMed ID: 32786002
[TBL] [Abstract][Full Text] [Related]
16. The MedSafer Study: A Controlled Trial of an Electronic Decision Support Tool for Deprescribing in Acute Care.
McDonald EG; Wu PE; Rashidi B; Forster AJ; Huang A; Pilote L; Papillon-Ferland L; Bonnici A; Tamblyn R; Whitty R; Porter S; Battu K; Downar J; Lee TC
J Am Geriatr Soc; 2019 Sep; 67(9):1843-1850. PubMed ID: 31250427
[TBL] [Abstract][Full Text] [Related]
17. Association of Deprescribing With Reduction in Mortality and Hospitalization: A Pragmatic Stepped-Wedge Cluster-Randomized Controlled Trial.
Kua CH; Yeo CYY; Tan PC; Char CWT; Tan CWY; Mak V; Leong IY; Lee SWH
J Am Med Dir Assoc; 2021 Jan; 22(1):82-89.e3. PubMed ID: 32423694
[TBL] [Abstract][Full Text] [Related]
18. Polypharmacy, the Elderly, and Deprescribing.
Jetha S
Consult Pharm; 2015 Sep; 30(9):527-32. PubMed ID: 26350893
[TBL] [Abstract][Full Text] [Related]
19. The DE-PHARM Project: A Pharmacist-Driven Deprescribing Initiative in a Nursing Facility.
Pruskowski J; Handler SM
Consult Pharm; 2017 Aug; 32(8):468-478. PubMed ID: 29029668
[TBL] [Abstract][Full Text] [Related]
20. Potentially inappropriate medication use as predictors of hospitalization for residents in nursing home.
Chae HW; Zhao J; Ah YM; Choi KH; Lee JY
BMC Geriatr; 2023 Aug; 23(1):467. PubMed ID: 37532993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
